Omega-3 fatty acid supplementation in schizophrenic patients

Human Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 39-46

  Mellor, Jan E ^a   Laugharne, Jonathan D E ^a   Peet, Malcolm ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Eicosapentenoic acid; Fatty acid; Schizophrenia; Tardive dyskinesia

Indexed keywords

FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; ERYTHROCYTE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0030027226     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-1077(199601)11:1<39::aid-hup742>3.0.co;2-#     Document Type: Article

References (21)

1. Bourre, J.-M., Bonneil, M., Chaudiere, J., Clement, M., Dumont, O., Durand, G., Lafont, H., Nalbone, G., Pascal, G. and Piciotti, M. (1992). Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system. In: Neurobiology of Essential Fatty Acids, Bazan, N. G., Murphy, M. G. and Toffano, G. (Eds), Plenum Press, New York, pp. 211-229.
2. Christensen, O. and Christensen, E. (1988). Fat consumption and schizophrenia. Acta Psychiatrica Scandanavica, 78, 587-591.
3. Davidson, B., Kurstjens, N. P., Patton, J. and Cantrill, R. C. (1988). Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices. European Journal of Pharmacology, 149, 317-322.
4. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biological Psychiatry, 36, 503-510.
5. Delion, S., Chalon, S., Herault, J., Guilloteau, D., Besnard, J.-C. and Durand, G. (1994). Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. Journal of Nutrition, 124, 2466-2476.
6. Department of Health (1991). Dietary reference values for food energy and nutrients for the United Kingdom. HMSO, London.
7. Glen, A. I. M., Glen, E. M. T., Horrobin, D. F., Vaddadi, K. S., Spellman, M., Morse-Fisher, N., Ellis, K. and Skinner, F. S. (1994). A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophrenia Research, 12, 53-61.
8. Guy, W. (Ed) (1976). ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Department of Health, Education and Welfare, Washington, DC, US, pp. 534-537.
9. Horrobin, D. F., Manku, M. S., Hillman, H. and Glen, A. I. M. (1991). Fatty acid levels in the brains of schizophrenics and normal controls. Biological Psychiatry, 30, 795-805.
10. Horrobin, D. F., Glen, A. I. M. and Vaddadi, K. (1994). The membrane hypothesis of schizophrenia. Schizophrenia Research, 13, 195-207.
11. Kay, S. R., Fiszbein, A. and Opier, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
12. Kinsella, J. E. (1990). Lipids, membrane receptors, and enzymes: effects of dietary fatty acids. Journal of Parenteral and Enterai Nutrition, 14, 200S-217S.
13. Manku, M. S., Horrobin, D. F., Huang, Y. S. and Morse, N. (1983). Fatty acids in plasma and red cell membranes. Lipids, 18, 906-908.
14. Peet, M., Laugharne, J., Horrobin, D. F. and Reynolds, G. P. (1994). Arachidonic acid: a common link in the biology of schizophrenia. Archives of General Psychiatry, 51, 665-666.
15. Peet, M., Laugharne, J., Rangarajan, N., Horrobin, D. and Reynolds, G. (1995). Depleted red cell membrane essential fatty acids in drug treated schizophrenic patients. Journal of Psychiatric Research, 29, 227-232.
16. Pettegrew, J. W., Keshavan, M. S., Panchalingam, K., Strychor, S., Kaplan, D. B., Tretta, M. G. and Allen, M. (1991). Alterations in brain high-energy phosphate and membrane phospholipid metabolism in firstepisode, drug-naive schizophrenics. Archives of General Psychiatry, 48, 563-568.
17. 31PMR spectro-scopy study. Schizophrenia Research, 13, 209-215.
18. Schooler, N. R. and Kane, J. M. (1982). Research diagnosis for tardive dyskinesia (RD-TD). Archives of General Psychiatry, 39, 486-487.
19. Vaddadi, K. S., Courtney, T., Gilleard, C. J., Manku, M. S. and Horrobin, D. F. (1989). A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Research, 27, 313-323.
20. Vaddadi, K. S. (1992). Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia. Prostaglandins Leukotrienes and Essential Fatty Acids, 46, 7-70.
21. Yao, J. K., Van Kammen, D. P. and Welker, J. A. (1994). Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophrenia Research, 13, 217-226.